SPI
Burden of disease in acute respiratory virus infections SPI02
Auditorium 3 - Breakout
Chairs
Ended
Now live
Upcoming
-
Welcome and introductionPaula TÄHTINENESWI Board Member, Turku University Hospital and University of Turku, FinlandStefania MAGGIESWI Board Member, National Research Council of Italy, Italy
-
Overview of burden of disease in acute respiratory virusesIvan SANZ-MUÑOZInstituto de Estudios de Ciencias de la Salud de Castilla y León, Spain
-
1. Risk factors associated with severe health outcomes among older adults hospitalized with respiratory syncytial virus (RSV): understanding the pre-vaccine era landscapeVajini ATUKORALEUniversity of Toronto, Canada
-
Respiratory infections and associated long-term complicationsFiona ECARNOTUniversity Hospital Besancon, France
-
Global Status of Adult Immunisation Post COVID-19Alba VILAJELIUWHO, Spain
-
Panel discussionPaula TÄHTINENESWI Board Member, Turku University Hospital and University of Turku, FinlandStefania MAGGIESWI Board Member, National Research Council of Italy, ItalyFiona ECARNOTUniversity Hospital Besancon, FranceAlba VILAJELIUWHO, SpainVajini ATUKORALEUniversity of Toronto, Canada
-
Closing remarksPaula TÄHTINENESWI Board Member, Turku University Hospital and University of Turku, FinlandStefania MAGGIESWI Board Member, National Research Council of Italy, Italy